Okayama, Japan

Hideki Matsui

This inventor holds 3 USPTO granted patents. Top assignees: Japan Science and Technology Agency, Agency of Industrial Science and Technology, Other. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Matsui. Retrieved from https://idiyas.com/inventor/hideki-matsui-loaezhq1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Okayama-shi, Okayama, JP (2007)
  • Okayama-shi, Okayama JP (2007 - 2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hideki Matsui

Introduction

Hideki Matsui is a notable inventor hailing from Okayama-shi, Okayama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds aimed at treating various medical conditions. With a total of 3 patents to his name, Matsui's work focuses on innovative solutions for immunologic diseases and cardiac hypertrophy.

Latest Patents

Matsui's latest patents include a membrane-permeable NFAT inhibitory peptide. This invention addresses conventional problems by providing a peptide compound that, when administered to patients suffering from immunologic diseases or cardiac hypertrophy, exhibits effectiveness quickly without side effects or antigenicity. The invention specifically relates to a peptide comprising several consecutive arginines and a NFAT-activity inhibitory peptide sequence, as well as an immunosuppressive agent and cardiac hypertrophy suppressive agent that utilize this peptide as the active ingredient.

Another significant patent is for inhibitors for continuous activation of calcineurin. This invention aims to provide a suppressant for neuronal cell death that is effective for various diseases. It inhibits the constitutive active formation of calcineurin while minimizing side effects. The invention includes peptides with specific amino acid sequences that serve as inhibitors of calcineurin cleavage.

Career Highlights

Throughout his career, Matsui has worked with various organizations, including the Japan Science and Technology Agency. His research and innovations have contributed to advancements in medical treatments and therapeutic approaches.

Collaborations

Matsui has collaborated with notable individuals in his field, including Masayuki Matsushita and Kazuhito Tomizawa. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Hideki Matsui's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…